CU Medical Boosts Bistos Stake to 49.22% via Third-Party Allotment, Raising Dilution Concerns
CU Medical acquired 1,359,751 shares of Bistos at 2,574 KRW per share via a third-party allotment, increasing its stake from 34.20% to 49.22%.
The acquisition cost of approximately 3.5 billion KRW was funded with the company's own cash, involving a large new share issuance equivalent to about 29.6% of Bistos' total outstanding shares.
The offering price represents a discount of about 19% to the market price, potentially deepening existing shareholder dilution, with the clear purpose of strengthening the controlling shareholder's influence.
[AI Summary]While CU Medical strengthened its control over Bistos through a discounted third-party allotment, the resulting dilution and lack of minority protection measures pose downside risks for existing shareholders.